| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
Moiz Rehmanjee
DFI | Director of Finance/CFO | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 26/10/2017 | |
| Director/Board Member | - | 30/09/2016 | |
Moiz Rehmanjee
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 24.88M | |
| +0.03% | -3.09% | +49.77% | +91.69% | 1,002B | |
| -0.76% | -2.95% | +50.93% | +66.34% | 649B | |
| +0.86% | -4.13% | +19.24% | +68.37% | 440B | |
| -0.80% | -0.43% | +28.92% | +35.45% | 346B | |
| -0.13% | -14.97% | +9.41% | +26.71% | 263B | |
| -1.90% | -2.72% | -2.72% | +7.41% | 250B | |
| -0.48% | -11.65% | +39.75% | +50.82% | 213B | |
| -1.06% | -4.23% | -14.70% | -57.36% | 201B | |
| -0.68% | -2.65% | +25.82% | +91.64% | 182B | |
| Average | -0.51% | -4.42% | +22.94% | +42.34% | 393.74B | |
| Weighted average by Cap. | -0.42% | -3.88% | +31.98% | +57.01% |
Employees
-
Sector
Pharmaceuticals
